Fresenius Kabi USA, LLC: Device Recall

Recall #Z-2232-2025 · 06/24/2025

Class II: Risk

Recall Details

Recall Number: Z-2232-2025
Classification: Class II
Product Type: Device
Recalling Firm: Fresenius Kabi USA, LLC
Status: Ongoing
Date Initiated: 06/24/2025
Location: North Andover, MA, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 19,225 units

Reason for Recall

Potential for external cassette leaks

Product Description

LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25). Product Code: SET-0013-25.

Distribution Pattern

US Nationwide distribution in the states of CA, CO, DE, FL, GA, ID, IL, MA, MD, MI, MN, MS, NJ, NV, OK, OR, SC, TX, VA, WA, WI.

Other Recalls by Fresenius Kabi USA, LLC

Class II: Risk 11/21/2025

Emphasizing instructions for LVP duration programming located in the IFU.
Class I: Dangerous 11/14/2025

Software version 5.10.1 and earlier contain anomalies that have the potential to cause serious patient harm or death.
Class I: Dangerous 11/06/2025

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Class II: Risk 11/03/2025

Downstream Occlusion alarms may occur during procedures using low flow infusion rates when a check valve* is added to the Ivenix Administration Set.
Class I: Dangerous 11/03/2025

Incorrect assembly of specific lot of LVP Primary Administration Set that could result in serious patient injury.

View all recalls by Fresenius Kabi USA, LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.